134th Annual Shattuck Lecture - Challenges to the Future of a Robust Medical Workforce in the US
As the health care landscape evolves, we face significant challenges in maintaining an adequate supply of well-trained health care professionals to meet the demands of our diverse population. Key topics include the impact of demographic
shifts, technological advancements, and policy changes. Dr. Walensky explores factors contributing to burnout and strategies for improving the well-being of healthcare professionals. Policy initiatives and reforms, as well as the impact of technological
innovations like telemedicine and AI, are also key focal points. This lecture provides a unique opportunity to come together and address the critical challenges facing the US health care system.
Shattuck Lecturer
Rochelle P. Walensky, MD, MPH
Executive Fellow, Harvard Business School and Harvard Kennedy School
19th Director of the Centers for Disease Control and Prevention (2021-2023)
Dr. Rochelle Walensky served as the 19th Director of the Centers for Disease Control and Prevention (2021-23), Professor of Medicine, Harvard Medical School
(2012-2021), and Chief of the Division of Infectious Diseases, Massachusetts General Hospital (2017-2021). Dr. Walensky is an infectious disease clinician whose research career is guided by a belief that the clinical and economic outcomes of medical decisions
can be improved through the explicit articulation of choices, the systematic assembly of evidence, and the careful assessment of comparative costs and benefits. She has focused these beliefs on mathematical model-based research toward the promotion of
global access to HIV prevention, screening, and care. Her ground-breaking work and oNew Linkver 300 research publications have motivated changes to US HIV testing and immigration policy; promoted expanded funding
for HIV-related research, treatment, and the President's Emergency Plan for AIDS Relief (PEPfAR); and led to policy revisions toward aggressive HIV screening – especially for the underserved – and earlier treatment in resource-limited international settings.
In light of these contributions, Dr. Walensky has been an active member of policy discussions at the WHO, UNAIDS, the DHHS HIV Guidelines Committee, and the NIH Office of AIDS Research. She is a member of the National Academy of Medicine and the Council
on Foreign Relations. Dr. Walensky served on the frontlines of the COVID-19 pandemic in Massachusetts until beginning her tenure at the CDC on January 20th, 2021. While at the CDC, Dr. Walensky led the nation - and the world - through unprecedented times,
navigating the darkest days of the COVID-19 pandemic and further facing the largest density of diverse infectious threats likely ever seen in this country. During her tenure, she participated in nearly 100 press conferences and countless media appearances,
and provided testimony at 17 Congressional hearings. Dr. Walensky received her BA (Biochemistry and Molecular Biology, 1991) from Washington University in St. Louis; her MD from the Johns Hopkins School of Medicine (1995) and her MPH from the Harvard
School of Public Health (Clinical Effectiveness, 2001). She completed her Internal Medicine residency at the Johns Hopkins Hospital (1995-1998) and her Infectious Disease fellowship at the Massachusetts General/Brigham and Women’s Hospital combined program
(1998-2001). She is married to Loren Walensky, MD, PhD, a physician-scientist and pediatric oncologist at the Dana-Farber Cancer Institute/Boston Children’s Hospital. The Doctors Walensky have 3 sons ages 20, 22, and 24.
Moderator
Eric J. Rubin, MD, MPH
Editor-In-Chief, The New England Journal of Medicine, NEJM Group
Eric J. Rubin, M.D., Ph.D., is Editor-in-Chief of the New England Journal of Medicine (NEJM), the world’s most widely read and oldest continuously published medical periodical, and NEJM Group, the publishing division of the Massachusetts Medical
Society. In addition to overseeing all editorial content and policies at NEJM Group, Dr. Rubin is a tuberculosis researcher and infectious disease physician. Joining NEJM as an Associate Editor in 2012, Dr. Rubin was appointed Editor-in-Chief in September
2019. He led the Journal through the height of the COVID-19 pandemic, mobilizing NEJM editors and staff to rapidly publish lifesaving research that was triple the standard volume of publication. In addition, he was instrumental in the launch of
a weekly podcast covering scientific and public health developments about the disease. Under his editorial leadership, NEJM Group launched NEJM Evidence (2022) and
NEJM AI (2023), a new monthly journal that explores cutting-edge applications of artificial intelligence and machine learning in clinical medicine. He also oversees NEJM Catalyst Innovations in Care
Delivery, NEJM Journal Watch, and educational resources for medical students and residents. Through podcasts, long-form videos, and multimedia content accessible on mobile devices, Dr. Rubin is focused on reaching authors, journal readers, and health
professionals with trusted health evidence. He believes that NEJM has a fundamental responsibility to build trust in science while communicating medical information that both new and experienced clinicians can act on immediately. Dr. Rubin is a Professor
of Medicine at Harvard Medical School and an adjunct Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health, training dozens of students and postdoctoral fellows. His lab studies the fundamental biology of tuberculosis
and how knowledge of that biology can be used to create new therapeutic approaches. A frequent keynote speaker, Dr. Rubin has collaborated with international science and global health organizations such as the Gates Foundation and Wellcome. He serves
on several scientific advisory boards for groups interested in infectious disease therapeutics, including the National Institutes of Health, the Vaccines and Related Biological Products Advisory Committee of the Food and Drug Administration, the Global
Alliance for TB Drug Development, and the Sub-Saharan African Network for TB/HIV Research Excellence. As an Associate Physician specializing in infectious diseases, he sees patients at Brigham and Women’s Hospital in Boston. Dr. Rubin is member of several
professional organizations including the National Academy of Medicine. A native of Brockton, Massachusetts, Dr. Rubin earned a Bachelor of Arts degree from Harvard College, an MD from Tufts University School of Medicine, and a PhD from Tufts University.
Course Objectives
Upon completion of this activity, learners should be able to:
- Discuss the current and future challenges facing the medical workforce.
- Explore trends in health care policy changes, demographic shifts, and technology advancements.
- Identify barriers and develop strategies to address recruitment and retention of underrepresented health care professionals.
Course Fees
MMS Member Physician: $40.00
MMS Resident/Student Member: Free
Non-MMS Member Physician: $90.00
Non-MMS Member Resident/Student: $20.00
Allied Health Professional: $32.00
Format & Estimated Time to Complete: Video/1 hour
Accreditation and Credit Information
Accreditation Statement
The Massachusetts Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education
for physicians.
AMA Credit Designation Statement
The Massachusetts Medical Society designates this enduring material for a maximum of 1.00 AMA PRA
Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for the Massachusetts Board of Registration in Medicine for risk management study.
National Commission on Certification of Physicians Assistant
(NCCPA)
Physician Assistants may claim a maximum of 1.00 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Exam/Assessment - You must complete the exam at the end of the course to receive AMA PRA
Category 1 Credit™.
Activity Term
Original Release Date: September 23, 2024
Review Date(s): N/A
Termination Date: September 23, 2027
System requirements:
Desktops/Laptops
Windows, XP, Vista, 7, 8
Mac OSX 10.6 higher
Most modern browsers including:
IE8,9,10
Firefox 18.0+
Chrome 26+
Safari 5+
Flash player is required for some Online CME courses.
Mobile/Tablet
iOS devices beginning with OS version 5 or higher (includes, iPhone, ipad and iTouch devices)
Android devices including tablets and phones.
Windows RT and tablets on Windows 8 are also supported.
